Solventum financials
$89.32−0.25%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 |
|---|---|---|
| Revenue | $8.32B | $8.25B |
| Gross profit | $4.45B | $4.59B |
| Gross margin | 53.5% | 55.6% |
| Operating income | $632.0M | $1.04B |
| Net income | $1.56B | $479.0M |
| Net margin | 18.7% | 5.8% |
| Diluted EPS | $8.88 | $2.76 |
| EBITDA | $1.12B | $1.59B |
| Operating cash flow | $369.0M | $1.19B |
| Free cash flow | -$10.0M | $805.0M |
| Diluted shares | 175.3M | 173.7M |
Balance sheet
| Period end | Dec 31 | Dec 31 |
|---|---|---|
| Cash & equivalents | $878.0M | $762.0M |
| Short-term investments | $0.00 | $0.00 |
| Total debt | $5.04B | $8.01B |
| Total assets | $14.29B | $14.46B |
| Total liabilities | $9.24B | $11.50B |
| Shareholders' equity | $5.05B | $2.96B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology